CLBCX
Price
$35.27
Change
-$0.35 (-0.98%)
Updated
Feb 21 closing price
Net Assets
244.57B
JABNX
Price
$46.73
Change
-$0.49 (-1.04%)
Updated
Feb 21 closing price
Net Assets
26.62B
Ad is loading...

CLBCX vs JABNX

Header iconCLBCX vs JABNX Comparison
Open Charts CLBCX vs JABNXBanner chart's image
American Funds American Balanced 529C
Price$35.27
Change-$0.35 (-0.98%)
VolumeN/A
Net Assets244.57B
Janus Henderson Balanced N
Price$46.73
Change-$0.49 (-1.04%)
VolumeN/A
Net Assets26.62B
CLBCX vs JABNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CLBCX vs. JABNX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBCX is a Hold and JABNX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
CLBCX has more cash in the bank: 245B vs. JABNX (26.6B). JABNX pays higher dividends than CLBCX: JABNX (2.03) vs CLBCX (1.52). CLBCX was incepted earlier than JABNX: CLBCX (23 years) vs JABNX (13 years). CLBCX is a more actively managed with annual turnover of: 171.00 vs. JABNX (92.00). CLBCX has a lower initial minimum investment than JABNX: CLBCX (250) vs JABNX (1000000). CLBCX annual gain was more profitable for investors over the last year : 8.39 vs. JABNX (7.52). JABNX return over 5 years is better than : 33.49 vs. CLBCX (26.92).
CLBCXJABNXCLBCX / JABNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years13 years-
Gain YTD2.7682.254123%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets245B26.6B921%
Annual Yield % from dividends1.522.0375%
Returns for 1 year8.397.52112%
Returns for 3 years16.4416.9197%
Returns for 5 years26.9233.4980%
Returns for 10 years53.3777.9868%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PFSI101.250.33
+0.33%
PennyMac Financial Services
ANTX1.13N/A
N/A
AN2 Therapeutics
DSGN4.91-0.10
-2.00%
Design Therapeutics
HAL26.26-0.73
-2.70%
Halliburton Company
INDI3.41-0.50
-12.79%
indie Semiconductor